Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionNatixis
Latest Disclosed Ownership48,192 shares
Latest Disclosed Value $ 21,519,656
Natixis ownership in 1VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Natixis filed a 13F-HR form disclosing ownership of 48,192 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $18,293,683 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 60,218 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -19.97% during the quarter. The current value of the position is $17,652,730 USD.

Natixis has a history of taking positions in derivatives of the underlying security (1VRTX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 48,192 -12,026 -19.97 21,520 -21.18 0.0696
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 60,218 30,412 102.03 27,300 133.87 0.0969
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 29,806 -1,155 -3.73 11,673 -15.31 0.0541
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 30,961 -24,473 -44.15 13,784 -48.55 0.0611
2025-07-18 2025-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 55,434 32,572 142.47 26,792 191.02 0.1459
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 55,434 32,572 26,792 0.1470
2025-02-13 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,862 -13,865 -37.75 9,207 -46.10 0.0562
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 36,727 -7,605 -17.15 17,081 -17.80 0.0963
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 44,332 -306 -0.69 20,779 11.36 0.1189
2024-05-13 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 44,638 -7,268 -14.00 18,659 -11.65 0.0970
2024-02-13 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 51,906 -129,266 -71.35 21,120 -66.48 0.1534
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 181,172 89,685 98.03 63,001 95.68 0.4822
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 91,487 73,987 422.78 32,195 483.98 0.2615
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,500 -60,978 -77.70 5,514 -75.67 0.0497
2023-02-24 2022-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 78,478 55,193 237.03 22,663 236.13 0.1271
2023-02-13 2022-12-31 13F Vertex Pharmaceuticals COM 92532F100 58,901 35,616 17,001 0.0000
2022-11-14 2022-09-30 13F Vertex Pharmaceuticals COM 92532F100 23,285 -9,232 -28.39 6,742 -26.42 0.0316
2022-08-12 2022-06-30 13F Vertex Pharmaceuticals COM 92532F100 32,517 27,221 513.99 9,163 563.02 0.0332
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,296 -15,127 -74.07 1,382 -69.19 0.0048
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 20,423 -166,652 -89.08 4,485 -86.78 0.0153
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 187,075 187,075 33,934 0.1173
2021-08-13 2021-06-30 13F VERTEX PHARMACEUTICALS CO 92532F100 0 -60,011 -100.00 0 -100.00
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS CO 92532F100 60,011 2,233 3.86 12,896 -5.56 0.0422
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 57,778 37,522 185.24 13,655 147.73 0.0496
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 20,256 -2,803 -12.16 5,512 -17.66 0.0406
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 23,059 13,516 141.63 6,694 194.76 0.0520
2020-05-14 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 9,543 -57,072 -85.67 2,271 -84.43 0.0178
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 66,615 -119,454 -64.20 14,587 -53.73 0.0904
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 186,069 29,516 18.85 31,524 9.81 0.2030
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 156,553 107,947 222.09 28,709 223.77 0.2270
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 48,606 -310,306 -86.46 8,867 -85.09 0.0558
2019-02-14 2018-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 358,912 196,919 121.56 59,475 90.48 0.4899
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 358,912 196,919 59,475
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 161,993 161,993 31,223 0.1805
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -487,993 -100.00 0 -100.00
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 487,993 467,713 2,306.28 73,131 2,272.07 0.5623
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 20,280 14,547 253.74 3,083 317.19 0.0284
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,733 -5,508 -49.00 739 -39.87 0.0084
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,241 -322,171 -96.63 1,229 -95.00 0.0153
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 333,412 333,412 0.00 24,562 0.2531
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 0 0 0.0000
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 0 0 0.0000
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -7,442 -100.00 0 -100.00
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,442 -93,962 -92.66 919 -92.32 0.0124
2015-05-22 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 101,404 -27,649 -21.42 11,963 -21.97 0.1644
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 129,053 -3,050 -2.31 15,331 3.34 0.2116
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 132,103 114,935 669.47 14,836 812.98 0.2287
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 17,168 -21,882 -56.04 1,625 -41.17 0.0195
2014-05-14 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 39,050 39,050 290.50 2,762 245.68 0.0359
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -10,000 -100.00 0 -100.00
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,000 10,000 799 0.0114
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-07-18 2025-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 24,000 11,599 n/a n/a n/a
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 24,000 11,599 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.